We just received data on a new analyst forecast for $BAC. Oppenheimer gave a rating of 'Outperform' for $BAC.
$BAC Analyst Ratings
Wall Street analysts have issued reports on $BAC in the last several months. We have seen 12 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 07/17/2025
- Truist Securities issued a "Buy" rating on 07/09/2025
- RBC Capital issued a "Outperform" rating on 06/30/2025
- Citigroup issued a "Buy" rating on 06/26/2025
- Morgan Stanley issued a "Overweight" rating on 06/23/2025
- Goldman Sachs issued a "Buy" rating on 06/10/2025
- Argus Research issued a "Buy" rating on 04/16/2025
To track analyst ratings and price targets for $BAC, check out Quiver Quantitative's $BAC forecast page.
$BAC Price Targets
Multiple analysts have issued price targets for $BAC recently. We have seen 15 analysts offer price targets for $BAC in the last 6 months, with a median target of $52.0.
Here are some recent targets:
- Chris Kotowski from Oppenheimer set a target price of $55.0 on 07/17/2025
- John McDonald from Truist Securities set a target price of $53.0 on 07/09/2025
- Saul Martinez from HSBC set a target price of $51.0 on 07/08/2025
- Gerard Cassidy from RBC Capital set a target price of $53.0 on 06/30/2025
- David George from Baird set a target price of $52.0 on 06/27/2025
- Keith Horowitz from Citigroup set a target price of $54.0 on 06/26/2025
- Betsy Graseck from Morgan Stanley set a target price of $49.0 on 06/23/2025
$BAC Congressional Stock Trading
Members of Congress have traded $BAC stock 10 times in the past 6 months. Of those trades, 3 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $BAC stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 05/08 and 2 sales worth up to $150,000 on 05/12, 04/07.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
- SENATOR JOHN BOOZMAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/15, 02/05.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
- REPRESENTATIVE GEORGE WHITESIDES sold up to $50,000 on 03/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BAC Hedge Fund Activity
We have seen 1,441 institutional investors add shares of $BAC stock to their portfolio, and 1,489 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BERKSHIRE HATHAWAY INC removed 48,660,056 shares (-7.2%) from their portfolio in Q1 2025, for an estimated $2,030,584,136
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 39,336,965 shares (-87.2%) from their portfolio in Q1 2025, for an estimated $1,641,531,549
- SANDERS CAPITAL, LLC added 26,334,535 shares (+117.0%) to their portfolio in Q1 2025, for an estimated $1,098,940,145
- WELLINGTON MANAGEMENT GROUP LLP added 24,042,326 shares (+36.5%) to their portfolio in Q1 2025, for an estimated $1,003,286,263
- CAPITAL WORLD INVESTORS added 22,594,045 shares (+25.6%) to their portfolio in Q1 2025, for an estimated $942,849,497
- CITIGROUP INC added 20,450,832 shares (+204.8%) to their portfolio in Q1 2025, for an estimated $853,413,219
- MORGAN STANLEY removed 17,979,308 shares (-14.4%) from their portfolio in Q1 2025, for an estimated $750,276,522
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
